Account Executive Sr. - Neuromuscular
UCB
Summary
To strengthen and support our up-and-coming launches within US Rare Disease Organization (RDO), we are seeking an Account Executive Sr. - Neuromuscular (AE) for our West Palm Beach, FL territory. The AE is an expert on the practices, delivery networks, and patient populations within their territory. They will represent UCB in the communities we serve as we strive toward transforming the lives of those living with Rare Diseases. Playing an integral role in identifying and building collaborative relationships with physicians and clinics, the AE embraces and executes marketing and sales strategies. They will master brand messaging, targeting, and digital technology to deliver persuasive, high-impact customer experiences tailored to distinct user segments while maintaining the highest ethical standards.
Job description
Major Accountabilities
- Consistently exceed territory sales objectives while operating with the highest level of ethics and integrity
- Advocate for Rare Disease patients and serve as the authority on the various tools and resources UCB offers to support physicians, pharmacists, and other health care providers
- Create and execute strategic business plans reflecting a thorough understanding of the local market conditions
- Master targeted disease states which include a deep understanding of patient journeys, standards of care and treatment drivers
- Continuously expand expertise of all treating and referring physicians, as well as payers, hospital systems, pharmacies, labs, and other components of the care continuum; maintain awareness and remain attentive to the dynamics between different stakeholders that influence patient treatment decisions
- Maintain strong relationships within the payer landscape to ensure providers are informed on coverage and reimbursement status; collaborate with the payer access team to ensure all relevant stakeholders are working with the most-up-to-date information to maximize access and affordability for patients using UCB products
- Foster strong relationships with patient advocacy groups and partner to support appropriate patient education and disease state awareness activities in the community
Requirements
- Bachelor's Degree
- 8+ years of field-based experience in sales, account management, and/or field reimbursement in biopharmaceuticals or healthcare
- 5+ years in a competitive specialty market segment
- 4+ years of Rare Disease experience in pharmaceuticals/Biologics
- Field experience with Buy-and-Bill medical benefits, Specialty Pharmacy, and HUB delivery models
- Verifiable record of sustained high sales performance and achievement in top 30% nationally
- Experience/involvement in successful product launches
- Ability to maximize impact of multichannel/digital tools and strategy/tactics with territory HCPs
- Command of key medical, scientific, and healthcare concepts, language, and practices related to neurology and rare diseases
- Experience serving a variety of call points – academic centers, community-based care, hospitals, and private office practices
- Preferred: 2+ years rare/orphan drug experience in competitive market
- Preferred: Significant CNS/neuroscience sales experience (to include epilepsy); Oncology, Hematology and/or Specialty reimbursement products requiring Specialty Pharmacy knowledge and expertise
- Preferred: Participation in recent successful product launches
- Preferred: Experience in supporting biologic therapy administered by a designated health care provider
- Preferred: Promotional product experience with REMS requirements
Benefits
- Hybrid-first work model
- 40% office time
Company overview
UCB is a global biopharmaceutical company headquartered in Brussels, Belgium, with a rich history dating back to 1928. The company specializes in developing innovative medicines for severe central nervous system and immunological conditions, with a particular focus on epilepsy, Parkinson's disease, and Crohn's disease. UCB operates in over 40 countries worldwide and employs approximately 9,378 people globally. The company's research and development efforts are centered on creating meaningful solutions that go beyond medicine, driven by patient experiences and scientific innovation. UCB's notable products include Keppra (levetiracetam) for epilepsy, Cimzia (certolizumab pegol) for autoimmune diseases, and Zyrtec (cetirizine) for allergies. With a strong commitment to sustainability and patient-centered care, UCB continues to advance transformative science and technologies to address unmet medical needs and improve the quality of life for patients worldwide.